Advancing Cervical Cancer Screening Through the Emergency Department - IIS
- Conditions
- Cervical CancersHPV
- Registration Number
- NCT06796738
- Lead Sponsor
- University of Rochester
- Brief Summary
Cervical cancer screening in the Emergency Department
- Detailed Description
This will be an effort to deploy HPV self-sampling among Emergency Department patients. Emergency Department patients, in the US and worldwide, are disproportionally under-screened for cervical cancer relative to the general population.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 200
- Cisgender women and transgender/non-binary individuals with a cervix,
- Age 25-65,
- Able to demonstrate decisional capacity to participate.
- Past hysterectomy with cervical removal,
- Known infection with HIV (as screening recommendations for people with HIV differ from the general population),
- Non-English speaking.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Uptake of Cervical Cancer Screening 150 days post initial intervention All intervention participants will receive a follow-up call at 150 days to assess uptake of any cervical cancer screening and for completion of the cervical cancer screening process. "Any cervical cancer screening" is defined as uptake of any aspect of the cervical cancer screening process, including self-sampling and/or clinic-based screening. "Completion of the cervical cancer screening process" is defined as completion of recommended clinic-based screening (including colposcopy if HPV 16/18+ or indicated).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Rochester
🇺🇸Rochester, New York, United States